Trials / Completed
CompletedNCT00458107
Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese and Non-Japanese Female Subjects
An Ascending Multiple Dose Study of the Safety, Pharmacokinetics, and Pharmacodynamics of SCA-136 Administered Orally to Healthy Japanese and Non-Japanese Female Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 64 (estimated)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- Female
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This study is being conducted to evaluate the safety and tolerability of ascending multiple oral doses of SCA-136 adminstered to healthy Japanese and non-Japanese female subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SCA-136 |
Timeline
- Start date
- 2007-04-01
- Completion
- 2007-09-01
- First posted
- 2007-04-09
- Last updated
- 2007-12-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00458107. Inclusion in this directory is not an endorsement.